Content Library

Toxicologic Pathology Forum: Adverse vs Nonadverse NFD in IT-Delivered Oligonucleotide Studies

Expert guidance on classifying adverse vs. nonadverse nerve fiber degeneration in intrathecal oligonucleotide nonclinical toxicity studies.

The Communication Disconnect in Device Development: A New Perspective from StageBio

Explore how early integration of toxicologic pathology can improve medical device safety, reduce miscommunication, and strengthen regulatory outcomes in device development.

The 4 Hidden Risks in Histopathology (and How to Avoid Them)

The road to bringing a medical device to market is fraught with potential regulatory pitfalls and decisions that can delay—or even derail—your efforts.

The feasibility and safety of a novel Encore PFO closure device in long-term porcine model

The limitations of current PFO occluders According to the Mayo Clinic, approximately one in four people have a hole between the left and right chambers of the heart known as a patent foramen ovale, or PFO. First-generation PFO occluders were designed to stop any resulting blood flow between the two chambers.

Upcoming Events

EuroTox 2026

Date: Sept 13-16
Location: Vienna, Austria

ESGCT 2026

Date: Oct 27-30
Location: Hamburg, Germany

Stay up to date on upcoming events by signing up for our quarterly newsletter!

Learn more about StageBio’s COVID-19 response